US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by Chemomab Therapeutics Ltd.

News headline image
Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference
From Chemomab Therapeutics Ltd.
Via GlobeNewswire
Tickers CMMB
News headline image
Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update
From Chemomab Therapeutics Ltd.
Via GlobeNewswire
Tickers CMMB
News headline image
Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis
From Chemomab Therapeutics Ltd.
Via GlobeNewswire
Tickers CMMB
News headline image
Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
From Chemomab Therapeutics Ltd.
Via GlobeNewswire
Tickers CMMB
News headline image
Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update
From Chemomab Therapeutics Ltd.
Via GlobeNewswire
Tickers CMMB
News headline image
Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference
From Chemomab Therapeutics Ltd.
Via GlobeNewswire
Tickers CMMB
News headline image
Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology
From Chemomab Therapeutics Ltd.
Via GlobeNewswire
Tickers CMMB
News headline image
Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit
From Chemomab Therapeutics Ltd.
Via GlobeNewswire
Tickers CMMB